OnKure Therapeutics, Inc.
OKURNASDAQHealthcareBiotechnology
Previous close
$3.94
+$0.01 · +0.25%
Aug 21, 4:00 PM ET
OKUR company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
48/100
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
61
Gaining
Sentiment
50
Mixed
Risk resilience
59
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
Market position
Day range
Current $3.94
$3.90$3.97
52-week range
Current $3.94
$2.23$5.38
- Open
- $3.95
- Previous close
- $3.93
- Volume
- 59.91K
- Market cap
- 159.56M USD
- 50-day average
- $4.2008
- -6.21% below average
- 200-day average
- $3.6335
- +8.44% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- -19.3M USD
- P/E (TTM)
- -1.13×
- P/B (TTM)
- 1.14×
- P/S (TTM)
- 0×
- EV / EBITDA
- 0.33×
- Earnings yield
- -151.84%
- Free cash flow yield
- -132.34%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -105.93%
- Return on assets
- -95.81%
- Return on invested capital
- -110.93%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 10.28×
- Altman Z-score
- 11.37
- Piotroski F-score
- 2 of 9
Financial statements
Income trends
Operating income
−62.95M USD-15.75%
Net income
−59.52M USD-12.99%
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | 830K USD | — | — | — | 50K USD |
| Gross profit | −830K USD | — | — | — | −50K USD |
| Research and development | 48.26M USD | 43.8M USD | 32.12M USD | 25.86M USD | 28.12M USD |
| Selling, general, and administrative | 14.69M USD | 10.59M USD | 4.82M USD | 3.9M USD | 11.65M USD |
| Operating expenses | 62.12M USD | 54.39M USD | 36.93M USD | 29.77M USD | 39.77M USD |
| Interest income | 3.44M USD | 2.01M USD | 1.62M USD | 254K USD | — |
| Interest expense | — | 300K USD | — | — | — |
| Depreciation and amortization | 830K USD | 662K USD | 560K USD | 387K USD | 50K USD |
| Operating income | −62.95M USD | −54.39M USD | −36.93M USD | −29.77M USD | −39.82M USD |
| Net income | −59.52M USD | −52.67M USD | −35.31M USD | −29.51M USD | −39.77M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$14.00
255.33% upsidePast 12 months12-month forecastHigh $14.00Average $14.00Low $14.00
OKUR news
OKUR peers
Continue in GoAI
Research OKURresearch.disclaimer